Indian Journal of Pharmacology Home 

DRUG WATCH
[View FULLTEXT] [Download PDF]
Year : 2016  |  Volume : 48  |  Issue : 1  |  Page : 86--87

Pure red cell aplasia due to azathioprine therapy for Crohn«SQ»s disease

Nagesh Kamath1, C Ganesh Pai1, Thylbert Deltombe2 
1 Department of Gastroenterology and Hepatology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India
2 Medical Student, CHRU Lille, Faculty Henri Warembourg, University of Lille2, Lille, France

Correspondence Address:
C Ganesh Pai
Department of Gastroenterology and Hepatology, Kasturba Medical College, Manipal University, Manipal, Karnataka
India

Various mechanisms contribute to anemia in inflammatory bowel diseases (IBD), drug-related causes being less frequent. The hematological and other adverse events of azathioprine (AZA) therapy are well documented, but drug-associated pure red cell aplasia (PRCA) is an uncommon event. We hereby describe two cases of AZA-associated PRCA in patients with Crohn«SQ»s disease. The diagnosis was supported by pathological reports, and prompt hematological recovery was seen with discontinuation of the offending drug. This report highlights the need to consider this rare entity in IBD patients in appropriate settings and for adopting adequate precautionary measures.


How to cite this article:
Kamath N, Pai C G, Deltombe T. Pure red cell aplasia due to azathioprine therapy for Crohn's disease.Indian J Pharmacol 2016;48:86-87


How to cite this URL:
Kamath N, Pai C G, Deltombe T. Pure red cell aplasia due to azathioprine therapy for Crohn's disease. Indian J Pharmacol [serial online] 2016 [cited 2022 Jan 20 ];48:86-87
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2016;volume=48;issue=1;spage=86;epage=87;aulast=Kamath;type=0